Pharmaceutical affairs law to revise on March 9

Published: 2001-02-28 14:49:00

Updated: 2001-02-28 14:49:00

As the extraordinary session of the National Assembly may be extended with 10 more days, the revised bill of the pharmaceutical affairs law seems to get passed through the National Assembly around the coming March 9.

The MDP, the ruling party, had the Supreme Commissioner's Meeting on Feb. 26 ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK